» Articles » PMID: 35212177

Successful Management of Feline Pemphigus Foliaceus with Pentoxifylline and Topical Hydrocortisone Aceponate

Overview
Journal Vet Med Sci
Date 2022 Feb 25
PMID 35212177
Authors
Affiliations
Soon will be listed here.
Abstract

The treatment regimen for feline pemphigus foliaceus (PF), an autoimmune disease caused by auto-antibodies against proteins of the desmosome junction, usually includes high doses of oral or parenteral immunosuppressive drugs, typically glucocorticoids. This case adds to a growing body of evidence that topical hydrocortisone aceponate is effective for the treatment of feline PF, and demonstrates the practical use of a non-invasive diagnostic method for histopathology when owners refuse a biopsy to support a clinical diagnosis of PF. Finally, this case highlights an international trend of owner-initiated treatment of feline infectious peritonitis (FIP) using unlicensed, unregistered drugs.

Citing Articles

Pemphigus foliaceus in cats.

Izydorczyk V, Pye C Can Vet J. 2024; 65(3):297-300.

PMID: 38434171 PMC: 10880387.


Successful management of feline pemphigus foliaceus with pentoxifylline and topical hydrocortisone aceponate.

Hobi S, Beatty J, Sandy J, Barrs V Vet Med Sci. 2022; 8(3):937-944.

PMID: 35212177 PMC: 9122467. DOI: 10.1002/vms3.768.

References
1.
Pedersen N, Perron M, Bannasch M, Montgomery E, Murakami E, Liepnieks M . Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis. J Feline Med Surg. 2019; 21(4):271-281. PMC: 6435921. DOI: 10.1177/1098612X19825701. View

2.
Bizikova P, Burrows A . Feline pemphigus foliaceus: original case series and a comprehensive literature review. BMC Vet Res. 2019; 15(1):22. PMC: 6327590. DOI: 10.1186/s12917-018-1739-y. View

3.
Bizikova P, Linder K, Olivry T . Fipronil-amitraz-S-methoprene-triggered pemphigus foliaceus in 21 dogs: clinical, histological and immunological characteristics. Vet Dermatol. 2014; 25(2):103-11, e29-30. DOI: 10.1111/vde.12117. View

4.
El-Darouti M, Marzouk S, Abdel Hay R, El-Tawdy A, Fawzy M, Leheta T . The use of sulfasalazine and pentoxifylline (low-cost antitumour necrosis factor drugs) as adjuvant therapy for the treatment of pemphigus vulgaris: a comparative study. Br J Dermatol. 2009; 161(2):313-9. DOI: 10.1111/j.1365-2133.2009.09208.x. View

5.
Wang G, Xu H, Wang Y, Gao X, Zhao Y, He C . Higher prevalence of human herpesvirus 8 DNA sequence and specific IgG antibodies in patients with pemphigus in China. J Am Acad Dermatol. 2005; 52(3 Pt 1):460-7. DOI: 10.1016/j.jaad.2004.10.882. View